about
Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disordersEffects of the pulsed electromagnetic field PST® on human tendon stem cells: a controlled laboratory studyDose-Related and Time-Dependent Development of Collagenase-Induced Tendinopathy in RatsFabrication of Innovative Silk/Alginate Microcarriers for Mesenchymal Stem Cell Delivery and Tissue Regeneration.High Levels of Circulating Type II Collagen Degradation Marker (CTx-II) Are Associated with Specific VDR Polymorphisms in Patients with Adult Vertebral Osteochondrosis.Multidifferentiation potential of human mesenchymal stem cells from adipose tissue and hamstring tendons for musculoskeletal cell-based therapyInteraction with hyaluronan matrix and miRNA cargo as contributors for in vitro potential of mesenchymal stem cell-derived extracellular vesicles in a model of human osteoarthritic synoviocytesSecreted Factors and EV-miRNAs Orchestrate the Healing Capacity of Adipose Mesenchymal Stem Cells for the Treatment of Knee OsteoarthritisTreatment with Human Amniotic Suspension Allograft Improves Tendon Healing in a Rat Model of Collagenase-Induced TendinopathyAutologous Microfragmented Adipose Tissue Reduces the Catabolic and Fibrosis Response in an In Vitro Model of Tendon Cell InflammationInflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint diseaseInnovative Visualization and Quantification of Extracellular Vesicles Interaction with and Incorporation in Target Cells in 3D MicroenvironmentsSignature Quality Attributes of CD146+ Mesenchymal Stem/Stromal Cells Correlate to High Therapeutic and Secretory Potency
P50
Q28073614-7E5DF056-DA11-4AE7-BA00-50A1EBE60E4BQ36107265-06101814-CBAA-484E-BF46-EBC974643C1FQ36108944-C6363549-0576-40EB-B526-AD8A0DE6D27CQ41661389-2A4E0C15-7913-4CEC-94E2-D2DBD4C4DEB1Q43554558-4AE30519-2D26-4418-93F2-2B0FBFDB9D1EQ57997406-77BFD69C-C786-4AAC-88F0-98E4275B46EAQ64105550-FB6CC318-AAF4-4A2C-9689-B020F6940E1DQ89944473-0B3DCDE9-DBA6-4569-905F-532DC02D5933Q91252441-4ED85BF7-099A-46F3-A4F8-F5FBC7E6A98FQ92308057-4DDE0A3C-3E39-448E-BA09-53E570FCD9FCQ94450959-BD19C6A4-86A9-40CA-BC3B-454EF3A467B9Q94591530-EFEFCA13-8997-412B-A42C-05F15CDA46F7Q94606386-D50749C7-0C0E-4676-AFB9-06AA4C91205B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlotta Perucca Orfei
@ast
Carlotta Perucca Orfei
@en
Carlotta Perucca Orfei
@es
Carlotta Perucca Orfei
@nl
type
label
Carlotta Perucca Orfei
@ast
Carlotta Perucca Orfei
@en
Carlotta Perucca Orfei
@es
Carlotta Perucca Orfei
@nl
prefLabel
Carlotta Perucca Orfei
@ast
Carlotta Perucca Orfei
@en
Carlotta Perucca Orfei
@es
Carlotta Perucca Orfei
@nl
P106
P1153
56955652900
57195469849
P31
P496
0000-0001-6162-8668